פריצת דרך עולמית: אושר טיפול למחלת התקפי השינה הפתאומיים "נרקולפסיה"

הערכה

A new treatment for narcolepsy, developed by Takeda, has received global approval. The drug targets the biological mechanism of the disorder and aims to address key symptoms like sudden sleep attacks and muscle tone loss. This marks a significant step forward for patients who previously had limited options targeting the root cause. Attention now turns to how quickly the treatment will reach healthcare systems and patients.